1 / 53

H.I.V.

H.I.V. WHAT IS HIV??. “Human Immunodeficiency Virus” A unique type of virus (a retrovirus) Invades the helper T cells (CD4 cells) in the body of the host (defense mechanism of a person) Threatening a global epidemic. Preventable, managable but not curable. OTHER NAMES FOR HIV.

tuttlec
Download Presentation

H.I.V.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. H.I.V.

  2. WHAT IS HIV?? • “Human Immunodeficiency Virus” • A unique type of virus (a retrovirus) • Invades the helper T cells (CD4 cells) in the body of the host (defense mechanism of a person) • Threatening a global epidemic. • Preventable, managable but not curable.

  3. OTHER NAMES FOR HIV • Former names of the virus include: • Human T cell lymphotrophic virus (HTLV-III) • Lymphadenopathy associated virus (LAV) • AIDS associated retrovirus (ARV)

  4. WHAT IS AIDS ??? • “Acquired Immunodeficiency Syndrome” • HIV is the virus that causes AIDS • Disease limits the body’s ability to fight infection due to markedly reduced helper T cells. • Patients have a very weak immune system (defense mechanism) • Patients predisposed to multiple opportunistic infections leading to death.

  5. AIDS (definition) • Opportunistic infections and malignancies that rarely occur in the absence of severe immunodeficiency (eg, Pneumocystis pneumonia, central nervous system lymphoma). • Persons with positive HIV serology who have ever had a CD4 lymphocyte count below 200 cells/mcL or a CD4 lymphocyte percentage below 14% are considered to have AIDS.

  6. “The viral genome” • Icosahedral (20 sided), enveloped virus of the lentivirus subfamily of retroviruses. • Retroviruses transcribe RNA to DNA. • Two viral strands of RNA found in core surrounded by protein outer coat. • Outer envelope contains a lipid matrix within which specific viral glycoproteins are imbedded. • These knob-like structures responsible for binding to target cell.

  7. Modes of HIV/AIDS Transmission

  8. Exchange of Bodily Fluids • Blood products • Semen • Vaginal fluids

  9. IntraVenous Drug Abuse • Sharing Needles • Without sterilization Increases the chances of contracting HIV • Unsterilized blades

  10. Through Sex • Unprotected Intercourse • Oral • Anal

  11. Mother-to-Baby • Before Birth • During Birth

  12. Myths about transmission

  13. NATURAL COURSE OF HIV/AIDS

  14. Stage 1 - Primary • Short, flu-like illness - occurs one to six weeks after infection • Mild symptoms • Infected person can infect other people

  15. Stage 2 - Asymptomatic • Lasts for an average of ten years • This stage is free from symptoms • There may be swollen glands • The level of HIV in the blood drops to low levels • HIV antibodies are detectable in the blood

  16. Stage 3 - Symptomatic • The immune system deteriorates • Opportunistic infections and cancers start to appear.

  17. Stage 4 - HIV  AIDS • The immune system weakens too much as CD4 cells decrease in number.

  18. Opportunistic Infections associated with AIDS CD4<500 • Bacterial infections • Tuberculosis (TB) • Herpes Simplex • Herpes Zoster • Vaginal candidiasis • Hairy leukoplakia • Kaposi’s sarcoma

  19. Opportunistic Infections associated with AIDS CD4<200 • Pneumocystic carinii • Toxoplasmosis • Cryptococcosis • Coccidiodomycosis • Cryptosporiosis • Non hodgkin’s lymphoma

  20. CD4 <50 • Disseminated mycobacterium avium complex (MAC) infection • Histoplasmosis • CMV retinitis • CNS lymphoma • Progressive multifocal leukoencephalopathy • HIV dementia

  21. TB & HIV CO-INFECTION • TB is the most common opportunistic infection in HIV and the first cause of mortality in HIV infected patients (10-30%) • 10 million patients co-infected in the world. • Immunosuppression induced by HIV modifies the clinical presentation of TB : • Subnormal clinical and roentgenpresentation • High rate of MDR/XDR • High rate of treatment failure and relapse (5% vs < 1% in HIV)

  22. Testing Options for HIV

  23. 23659874515 Anonymous Anonymous Testing • No name is used • Unique identifying number • Results issued only to test recipient

  24. Blood Detection Tests

  25. Urine Testing • Urine Western Blot • As sensitive as testing blood • Safe way to screen for HIV • Can cause false positives in certain people at high risk for HIV

  26. Oral Testing • Orasure • The only FDA approved HIV antibody. • As accurate as blood testing • Draws blood-derived fluids from the gum tissue. • NOT A SALIVA TEST!

  27. Treatment Options

  28. HAART = highly active anti-retroviral treatment

  29. Antiretroviral Drugs (HAART) • Nucleoside Reverse Transcriptase inhibitors • AZT (Zidovudine) • Non-Nucleoside Transcriptase inhibitors • Viramune (Nevirapine) • Protease inhibitors • Norvir (Ritonavir)

  30. EFFECTIVENESS OF HAART IN REDUCING MORTALITY

  31. HEALTH CARE FOLLOW UP OF HIV INFECTED PATIENTS For all HIV-infected individuals: • CD4 counts every 3–6 months    • Viral load tests every 3–6 months and 1 month following a change in therapy    • PPD    • INH for those with positive PPD and normal chest radiograph    • RPR or VDRL for syphilis   • Toxoplasma IgG serology    • CMV IgG serology    • Pneumococcal vaccine    • Influenza vaccine in season    • Hepatitis B vaccine for those who are HBsAb-negative    • Haemophilus influenzae type b vaccination     • Papanicolaou smears every 6 months for women

  32. For HIV-infected individuals with CD4 < 200 cells/mcL: • Pneumocystis jiroveci1 prophylaxis • For HIV-infected individuals with CD4 < 75 cells/mcL: • Mycobacterium avium complex prophylaxis   • For HIV-infected individuals with CD4 < 50 cells/mcL: • Consider CMV prophylaxis

  33. PRIMARY PREVENTION:Five ways to protect yourself? • Abstinence • Monogamous Relationship • Protected Sex • Sterile needles • New shaving/cutting blades

  34. Abstinence • It is the most effective method of not acquiring HIV/AIDS. • Refraining from unprotected sex: oral, anal, or vaginal. • Refraining from intravenous drug use

  35. Monogamous relationship • A mutually monogamous (only one sex partner) relationship with a person who is not infected with HIV • HIV testing before intercourse is necessary to prove your partner is not infected

  36. Protected Sex • Use condoms every time you have sex • Always use latex or polyurethane condom (not a natural skin condom) • Always use a latex barrier during oral sex

  37. When Using A Condom Remember To: • Make sure the package is not expired • Make sure to check the package for damages • Do not open the package with your teeth for risk of tearing • Never use the condom more than once • Use water-based rather than oil-based condoms

  38. GLOBAL ESTIMATES 2008

  39. ESCALATING EPIDEMIC !!! Source: WHO/UNAIDS/UN The Millennium Development Goals Report, 2009, p.32 and WHO.

  40. HIV PREVALENCE IN VARIOUS REGIONS Sub-Saharan Africa South/South-East Asia 42% Latin America Eurasia North America East Asia Western Europe Total = 39.4 million North Africa/Middle East Caribbean < Oceania Source: UNAIDS, AIDS Epidemic Update, December 2004.

  41. NEWLY INFECTED CASES OF HIV IN VARIOUS REGIONS 63% Total = 4.9 million Source: UNAIDS, AIDS Epidemic Update, December 2004

  42. ESTIMATED HIV BURDEN IN PAKISTAN • 0.1% of the adult population in Pakistan • Total Population (2008) = 180,800,000 • People living with HIV/AIDS (2008) = 96,000 • Women (aged 15+) with HIV/AIDS (2008) = 27,000 • Children with HIV/AIDS (2008) = nd • Adult HIV prevalence(%) (2008) = 0.1% • AIDS deaths (2008) = 5,100

  43. ESCALATING EPIDEMIC OF HIV IN HIGH RISK GROUPS IN PAKISTAN

  44. POTENTIAL THREATS IN PAKISTAN • 100,000 commercial sex workers with poor safe sex awareness in three major cities • Estimated 60,000 iv drug users in pakistan (1 in 5 infected with HIV) • 38,000 homosexuals reported in lahore in 2002 • 40% of 1.5 million annual blood donors not screened for HIV • 20% of blood transfusions come from professional donors with high prevalence of infectious diseases • Significantly large number of migrants and refugees.

  45. UNDER-REPORTING Until September 2004, only 300 cases of full-blown AIDS and another 2300 cases of HIV infection were reported to the National AIDS Control Program. The reasons for under reporting are: • Social stigma attached to the infection, • Limited surveillance • Voluntary counseling and testing systems • Lack of knowledge among the general population and health practitioners.

  46. NATIONAL RESPONSE TO HIV/AIDS • Pakistan’s Federal Ministry of Health initiated a National AIDS Prevention and Control Program (NACP) in 1987 • In its early stages, the program was focused on diagnosis of cases that came to hospitals, but progressively began to shift toward a community focus • The government has indicated in the recent scaling up of its response to HIV/AIDS, more needs to be done.

  47. NON GOVERNMENTAL ORGANIZATIONS • 54 NGOs are involved in HIV/AIDS public awareness and in the care and support of persons living with HIV/AIDS. • Also working on education and prevention interventions targeting sex workers, truck drivers, and other high-risk groups. • But reaching less than 5 percent of the vulnerable population.

  48. WORLD BANK RESPONSE • Largest financer of HIV/AIDS program in Pakistan • Providing 37.1 million US dollars • Enhanced program is making encouraging progress with expansion of coverage.

More Related